Propranolol therapy in infantile hemangioma: correlation of age and duration of treatment to the outcomes
Abstract Background Infantile hemangioma (IH) is the commonest vascular tumor affecting children that appears in the first 2 weeks of life and follows a proliferative phase that continues during the first year of life. After then, it undergoes involution, which lasts for several months or years depe...
Saved in:
Main Authors: | Ali Farooq Al-Mayoof (Author), Ali Egab Joda (Author), Osama Esmaeel Almushhadany (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemangioma infantil tratado com propranolol Propranolol treatment for hemangioma of infancy
by: Flavia Kakiuti Bonini, et al.
Published: (2011) -
Variable response to propranolol therapy for infantile hemangiomas
by: Vishesh Jain, et al.
Published: (2012) -
Propranolol therapy for infantile hemangioma: our experience
by: Zhang L, et al.
Published: (2017) -
Therapy for involuting infantile hemangioma: Propranolol effectiveness
by: Luz Orozco-Covarrubias, et al.
Published: (2018) -
Propranolol in the Treatment of Infantile Hemangiomas
by: Tan X, et al.
Published: (2021)